| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |